Search is Powered by Google
Lymphoma / Leukemia News

Do You Know Your Nodes? Message From The Lymphoma Association And Leukaemia CARE, UK

Main Category: Lymphoma / Leukemia
Also Included In: Cancer / Oncology;  Blood / Hematology
Article Date: 29 Sep 2008 - 9:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:5 stars

5 (2 votes)

Health Professional:not yet rated

Article Opinions: 0 posts

Know Your Nodes! That's the message the Lymphoma Association and Leukaemia CARE are spreading ahead of World Lymphoma Awareness Day (WLAD), an event held annually on September 15th which aims to inform the public about lymphoma; the sixth most common cancer in the UK.

In order to recognise WLAD this year, the charities, both members of the Lymphoma Coalition, are encouraging people to go online and take part in a quiz which tests people's understanding of their lymph nodes, the lymphatic system and gives information on the common signs and symptoms of the cancer.

Julie Mercer, Head of Communications for the Lymphoma Association says: "If people have a better understanding of how their lymphatic system works, it means that potential symptoms may be recognised sooner, leading to earlier detection of the cancer. Early detection and diagnosis is key to the success of treatment so we really want as many people as possible to take the quiz and educate themselves."

You can take the quiz by visiting http://www.knowyournodes.org.uk

About Leukaemia CARE

Leukaemia CARE exists to provide vital care and support to all those whose lives have been affected by leukaemia, lymphoma, myeloma and the allied blood disorders. Our work extends to the welfare of families and carers, as well as that of patients themselves. Quite simply...'supporting a quality of life for all'

Leukaemia CARE




Customized Homepage Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Diabetes Schizophrenia

customize your homepage

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader

customize your homepage


Monitoring and Adherence in CML image Monitoring and Adherence in CML

Imatinib, or Gleevec, is a targeted anti-cancer drug that can keep chronic myelogenous leukemia (CML) in check for most patients for many years. It is important for patients to take imatinib as prescribed by their doctor to fight the disease and to guard against resistance...

Introduction to CML image Introduction to CML

Chronic myeloid leukemia is a form of cancer that typically occurs in adults over the age of 40. Here's what you need to know about this disease...

View more videos...